The recent acquisition of Norwegian point-of-care diagnostics platform SpinChip by bioMérieux for EU...
Redeye comments on Freemelt ahead of its Q4 results.
Strong Q4 with a beat on all headline items... ...adds more fuel to '25e growth: guidance remains to...
Vaisala’s Q4 turned out to be very strong as the operating result was higher than the company previo...
Analyst Group har med Nosa Plugs ingått avtal om kontinuerlig analysbevakning, innefattande bl.
Redeye briefly comments on MedCap releasing preliminary Q4 2024 figures, significantly undershooting...
Redeye is impressed by the strong preliminary Q4 results, demonstrating an EBIT breakeven several qu...
Q4 report due Thursday, 13 February We cut adj. EBITA 4%/3%/3% on '24e/'25e/'26e Share is trading at...
Duell reported Q1 net sales at EUR 28.3m, just surpassing our forecast of EUR 27.
Redeye takes a positive stance on the news that Sivers is raising SEK108m through a directed share i...
Peer and competitor in Finland, HKFoods is out with a positive profit warning stating its 2024 compa...
Redeye makes a brief comment on today’s news of the CEO replacement.
Redeye strengthens its positive view of Teneo AI following preliminary Q4 figures showing a substant...
Q4e: clean EBIT of ~SEK -90m, Q1 should be better Pulp prices down, but hikes announced Fair value r...
Preliminary Q4 EBITA ~40% below FactSet consensus We expect consensus to cut '25 EBITA by ~15% and '...
